Free Trial

LENZ Therapeutics (LENZ) Insider Trading & Ownership

LENZ Therapeutics logo
$39.89 +0.26 (+0.66%)
Closing price 09/9/2025 04:00 PM Eastern
Extended Trading
$40.45 +0.56 (+1.40%)
As of 07:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LENZ Therapeutics (NASDAQ:LENZ) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.90%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
$15.50M
Number Of
Insiders Selling
(Last 3 Years)
0
Get LENZ Insider Trade Alerts

Want to know when executives and insiders are buying or selling LENZ Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LENZ Insider Buying and Selling by Quarter

LENZ Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/13/2024James W MccollumDirectorBuy31,332$15.99$500,998.68  
3/21/2024Ra Capital Management, L.P.DirectorBuy998,009$15.03$15,000,075.27  
(Data available from 1/1/2013 forward)

LENZ Insider Trading Activity - Frequently Asked Questions

The list of insiders at LENZ Therapeutics includes James W Mccollum, and Ra Capital Management, L.P.. Learn more on insiders at LENZ.

6.90% of LENZ Therapeutics stock is owned by insiders. Learn more on LENZ's insider holdings.

The following insiders have purchased LENZ shares in the last 24 months: James W Mccollum ($500,998.68), and Ra Capital Management, L.P. ($15,000,075.27).

Insiders have purchased a total of 1,029,341 LENZ shares in the last 24 months for a total of $15,501,073.95 bought.

LENZ Therapeutics Key Executives

  • Mr. Evert B. Schimmelpennink (Age 52)
    President, CEO, Secretary & Director
    Compensation: $886.54k
  • Mr. Shawn Olsson (Age 41)
    Chief Commercial Officer
    Compensation: $532.13k
  • Mr. Marc G. Odrich M.D. (Age 65)
    Chief Medical Officer
    Compensation: $576.95k
  • Mr. James W. McCollumMr. James W. McCollum (Age 69)
    Co-Founder & Director
  • Mr. Gerald Horn
    Senior Scientific Advisor & Founder
  • Mr. Daniel R. Chevallard CPA (Age 44)
    Chief Financial Officer
  • Mr. Domenick Porfidia
    Vice President of Sales
  • Mr. David Murphy
    Senior Director of Marketing & Alliance Development
  • Mr. Marvin J. Garrett (Age 73)
    Senior Vice President of Regulatory & Quality


This page (NASDAQ:LENZ) was last updated on 9/10/2025 by MarketBeat.com Staff
From Our Partners